期刊文献+

重复注射A型肉毒毒素治疗痉挛型脑性瘫痪 被引量:2

Effect of Local Intramuscular Repeated Injection with Botulinum Toxin-A for Treatment of Spastic Cerebral Palsy
下载PDF
导出
摘要 目的观察重复肌肉注射A型肉毒毒素(BTX-A)治疗痉挛型脑性瘫痪的疗效。方法用BTX-A对30例重度痉挛型脑性瘫痪患儿进行2次局部肌肉注射,2次注射间隔为3个月,注射剂量4 U/(kg.次)。以改良阿氏量表(MAS)评定肌张力,以运动评价量表(PRS)评定运动功能。分析注射前、2次重复注射后3个月的肌张力、PRS分数变化。应用配对t检验进行统计分析。结果BTX-A第2次治疗前后肌张力、PRS分值均具有显著性差异(P均<0.001)。结论局部重复肌肉注射BTX-A能有效治疗重度痉挛型脑性瘫痪,提高运动功能。 Objective To observe the curative effect of botulinum toxin A(BTX -A)repeated intramuscular injection for treatment of ,serious spastic cerebral palsy. Methods Thirty eases with ,serious spastic cerebral palsy received local repeated intramuscular injection. The interval time was 3 months. The dose of BTX-A was 4 U/kg. The muscle tone was assessed with the modified ashworth scale and range of motion with physical rating scale(PRS). The indexes were evaluated before injection and 3 months after the second injection. Paired-samples t-test was used in the statistic analysis. Result The muscle tone and PRS had renmrkable improvement after second therapy with BTX-A(P〈0.001). Conclusion Local repeated intramuscular injection with BTX-A can effectively treat serious spastic cerebral palsy.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2005年第8期799-800,共2页 Journal of Applied Clinical Pediatrics
关键词 脑性瘫痪 肌痉挛 肉毒毒素类 肌肉注射 cerebral palsy muscular spasticity hotulinum toxin intranmscular injection
  • 相关文献

参考文献2

二级参考文献18

  • 1Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 2003;60:1186-8.
  • 2Lew MF, Adornato BT, Duane DD, et al. Botulinum toxin type B:A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 1997;49:701-7.
  • 3Brashear A, Lew MF, Dykstra DD, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999;53:1439-46.
  • 4Brin MF, Lew MF, Adler CH, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type-A resistant cervical dystonia. Neurology 1999;53:1431-8.
  • 5Parish JL. Commercial preparations and handling of botulinum toxin type A and type B. Clin Dermatol 2003;21:481-4.
  • 6Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990;53:633-9.
  • 7Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 2004;75:951-7.
  • 8Colosimo C, Chianese M, Giovannelli M, et al. Botulinum toxin type B in blepharospasm and hemifacial spasm. J Neurol Neurosurg Psychiatry 2003;74:687.
  • 9Figgitt DP, Noble S. Botulinum toxin B: a review of its therapeuric potential in the management of cervical dystonia. Drugs 2002;62:705-22.
  • 10Baumann L, Black L. Botulinum toxin type B (Myobloc). Dermatol Surg 2003;29:496-500.

共引文献5

同被引文献26

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部